ArticleEuropean journal of medicinal chemistry2023

Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models.

Fabio Francavilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.